Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studies. [electronic resource]
- Analytical chemistry Nov 2012
- 9865-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1520-6882
10.1021/ac3021483 doi
Animals Antineoplastic Agents--chemistry Chromatography, Liquid Deuterium Exchange Measurement Dogs Magnetic Resonance Spectroscopy Mass Spectrometry Microsomes, Liver--metabolism Oxygen--chemistry Quinoxalines--chemistry Rats